TechFlow news, September 22 — According to GLOBE NEWSWIRE, Nasdaq-listed Helius Medical Technologies (NASDAQ: HSDT) announced its first acquisition of Solana (SOL) tokens as part of its digital asset treasury strategy.
The company currently holds over 760,190 SOL tokens at an average cost of $231, in addition to more than $335 million in cash, which is intended to further advance its digital asset treasury strategy.
Joseph Chee, the company's Executive Chairman, stated that it has received support from multiple stakeholders within the Solana ecosystem, including staking providers and DeFi protocols. Cosmo Jiang, General Partner at Pantera Capital, noted that the initial accumulation cost was below recent market prices, demonstrating the team's focus on maximizing shareholder value.
